Ascendis Pharma AS (ASND) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.05x

Ascendis Pharma AS (ASND) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $3.30 Million (capex $3.30 Million ) from operating cash flow of $70.67 Million. Check Ascendis Pharma AS cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.05x
(Capex + Investments) / Operating CF

Total Reinvested

$3.30 Million
Capex + Investments

Operating Cash Flow

$70.67 Million
USD

Capital Expenditures

$3.30 Million
USD

Ascendis Pharma AS Cash Flow Reinvestment Rate (2013–2025)

Historical reinvestment intensity for Ascendis Pharma AS across 2 annual periods. Explore ASND long-term investments to assets to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Ascendis Pharma AS (2013–2025)

Year-by-year capital reinvestment analysis for Ascendis Pharma AS. For live market cap and broader valuation context, see market value of Ascendis Pharma AS.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 0.16x $8.15 Million $51.77 Million $8.15 Million ▼ -16.9%
2013 0.19x $1.20 Million $6.31 Million $1.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow